Search Results - "Doescher, J."

Refine Results
  1. 1

    The 8th edition of the AJCC Cancer Staging Manual : Updates in otorhinolaryngology, head and neck surgery by Doescher, J, Veit, J A, Hoffmann, T K

    Published in HNO (01-12-2017)
    “…The TNM system is an established tool for classification of solid tumors by means of tumor size and extent, the involvement of local lymph nodes, and the…”
    Get full text
    Journal Article
  2. 2

    Age-related changes in T lymphocytes of patients with head and neck squamous cell carcinoma by Jeske, S S, Schuler, P J, Doescher, J, Theodoraki, M N, Laban, S, Brunner, C, Hoffmann, T K, Wigand, M C

    Published in Immunity & ageing (12-02-2020)
    “…The number of aging cancer patients has increased continuously and will do so further in the future. The immune system of elderly people experiences critical…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Influence of travel burden on tumor classification and survival of head and neck cancer patients by Vahl, J. M., von Witzleben, A., Welke, C., Doescher, J., Theodoraki, M. N., Brand, M., Schuler, P. J., Greve, J., Hoffmann, T. K., Laban, S.

    Published in European archives of oto-rhino-laryngology (01-11-2021)
    “…Purpose Cancer patients have to overcome various barriers to obtain diagnostics and treatment at head and neck cancer centers. Travel distance to a specialized…”
    Get full text
    Journal Article
  5. 5

    Subcutaneous foreign body granuloma after neck dissection and adjuvant radiation by Mytilineos, D, Hoffmann, T K, Brunner, C, Weißinger, S, Möller, P, Doescher, J

    Published in HNO (01-12-2019)
    “…This article presents an oncologic patient with oropharyngeal cancer. After surgery with bilateral neck dissection and adjuvant radiation, the patient…”
    Get full text
    Journal Article
  6. 6

    Tumor biology of oropharyngeal carcinoma by Laban, S, Brand, M, Ezić, J, Doescher, J, Völkel, G, Kestler, H A, Brunner, C, Hoffmann, T K

    Published in HNO (01-04-2021)
    “…Etiologically, oropharyngeal squamous cell carcinoma (OPSCC) can be divided into OPSCC caused by noxious agents and human papillomavirus (HPV)-driven…”
    Get full text
    Journal Article
  7. 7

    Tumor microenvironment in salivary gland carcinomas: Consequences for new therapeutic concepts by Meyer, M F, Arolt, C, Kansy, B A, Doescher, J, Quaas, A, Beutner, D, Lang, S, Klußmann, J P

    Published in HNO (01-12-2020)
    “…Salivary gland carcinomas (SGCs) are rare tumors which represent a challenge for diagnosis and therapy due to their histological diversity and the different…”
    Get full text
    Journal Article
  8. 8

    Salivary gland malignancies-highlights of the 2019 ASCO Annual Meeting by Doescher, J, Schuler, P J, Greve, J, Meyer, M F, Weissinger, S, Hoffmann, T K, Laban, S

    Published in HNO (01-12-2019)
    “…Due to their comparatively low incidence, salivary gland carcinomas have only been the subject of isolated clinical studies in recent years. In addition,…”
    Get full text
    Journal Article
  9. 9

    Application of a computer-assisted flexible endoscope system for transoral surgery of the hypopharynx and upper esophagus by Friedrich, Daniel T., Scheithauer, M. O., Greve, J., Rotter, N., Doescher, J., Hoffmann, T. K., Schuler, P. J.

    Published in European archives of oto-rhino-laryngology (01-05-2017)
    “…Zenker’s diverticulum is a common pathology in the transition zone of the posterior hypopharynx and esophagus. Surgical treatment is routinely performed by ENT…”
    Get full text
    Journal Article
  10. 10

    Immunotherapy for head and neck cancer : Highlights of the 2019 ASCO Annual Meeting by Doescher, J, Busch, C-J, Wollenberg, B, Dietz, A, Würdemann, N, Schuler, P, Hoffmann, T K, Laban, S

    Published in HNO (01-12-2019)
    “…In the field of immunotherapy of head and neck squamous cell carcinoma (HNSCC), a high level of study activity can still be observed. The results of the…”
    Get full text
    Journal Article
  11. 11

    Polyfunctionality of CD4+ T lymphocytes is increased after chemoradiotherapy of head and neck squamous cell carcinoma by Doescher, J., Jeske, S., Weissinger, S. E., Brunner, C., Laban, S., Bölke, E., Hoffmann, T. K., Whiteside, T. L., Schuler, P. J.

    Published in Strahlentherapie und Onkologie (01-05-2018)
    “…Background For head and neck squamous cell cancer (HNSCC), standard therapy consists of surgery, radiation, and/or chemotherapy. Antineoplastic immunotherapy…”
    Get full text
    Journal Article
  12. 12

    Immunotherapy highlights of the ASCO annual meeting 2018 for head and neck cancers by Laban, S, Doescher, J, Busch, C-J, Wollenberg, B, Dietz, A, Würdemann, N, Schuler, P J, Hoffmann, T K

    Published in HNO (01-12-2018)
    “…Immunotherapeutic strategies are becoming increasingly more important for head and neck cancer and numerous clinical trials were presented at the annual…”
    Get full text
    Journal Article
  13. 13

    Immuno-, radio-, and chemotherapeutic studies in head and neck cancer : Highlights of the ASCO Annual Meeting 2017 by Schuler, P J, von Witzleben, A, Doescher, J, Wollenberg, B, Dietz, A, Hoffmann, T K

    Published in HNO (01-03-2018)
    “…In recent years, immunotherapy has been shown to be a promising approach for the treatment of various tumor entities. Due to further pharmacological…”
    Get full text
    Journal Article
  14. 14

    Immunomodulation as innovative therapy for head and neck tumors : Current developments by Schuler, P J, Doescher, J C, Laban, S, Hoffmann, T K

    Published in HNO (01-07-2016)
    “…Head and neck squamous cell carcinoma (HNSCC) is characterized by its intense immune suppression and its elaborate immune escape mechanisms. Due to the fact…”
    Get full text
    Journal Article
  15. 15

    Immunotherapy of head and neck tumors: Highlights of the ASCO Meeting 2015 by Laban, S, Doescher, J, Schuler, P J, Bullinger, L, Brunner, C, Veit, J A, Hoffmann, T K

    Published in HNO (01-09-2015)
    “…In recent years, new immunotherapeutic drugs have become available: the so-called immune checkpoint modulators. With these drugs, unprecedented treatment…”
    Get full text
    Journal Article Conference Proceeding
  16. 16

    Diagnostik und Therapie maligner Nasentumoren by Doescher, J., Ott, S., Kövi, J., Steinacker, J., Hoffmann, T. K., Sommer, F.

    Published in Best practice onkologie (01-10-2021)
    “…Zusammenfassung Die Behandlung von Karzinomen der Nasenhaupt- und Nasennebenhöhle ist aufgrund der Heterogenität der Tumoren und der anatomischen Verhältnisse…”
    Get full text
    Journal Article
  17. 17

    Oncoimmunology in old age by Wigand, M C, Jeske, S, Hahn, J, Doescher, J, Laban, S, Hoffmann, T K, Schuler, P J

    Published in HNO (01-03-2020)
    “…Physiological aging processes of the immune system are associated with an increased susceptibility to infectious, autoimmune and tumor diseases. In accordance…”
    Get full text
    Journal Article
  18. 18

    Die 8. Ausgabe der TNM‑Klassifikation: Neuerungen für das Fachgebiet Hals‑Nasen‑Ohren‑Heilkunde, Kopf- und Halschirurgie by Doescher, J., Veit, J. A., Hoffmann, T. K.

    Published in HNO (01-12-2017)
    “…Zusammenfassung Hintergrund Das TNM-System stellt ein etabliertes Hilfsmittel zur Klassifizierung solider Tumoren anhand von Tumorgröße sowie -ausdehnung, dem…”
    Get full text
    Journal Article
  19. 19

    Update on HPV-associated head and neck cancers-highlights of the 2024 ASCO Annual Meeting by Sharma, S J, Klussmann, J P, Döscher, J, Hoffmann, T K, Laban, S

    Published in HNO (25-10-2024)
    “…Human papillomavirus (HPV)-associated head and neck squamous cell carcinoma (HNSCC) is becoming increasingly important in head and neck oncology. At this…”
    Get full text
    Journal Article
  20. 20